Barclays »

ImmuCell Corporation shares owned by Barclays

Quarter-by-quarter ownership of ImmuCell Corporation (ICCC) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in ImmuCell Corporation

Tip: Access up to 7 years of quarterly data

All positions including ImmuCell Corporation held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmuCell Corporation by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $43 7 6.29
2012-09-30 $0 29 0.00

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding ImmuCell Corporation

Vanguard Group
Renaissance Technologies
Cresset Asset Management
Morgan Stanley
Bleichroeder
Dauntless Investment Group
Geode Capital Management
Dimensional Fund Advisors
Shufro Rose & Co
Northern Trust
Alan Leist III
Steadtrust
Citadel Advisors
HighTower Advisors
BlackRock

View all funds holding ImmuCell Corporation